Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Colorcon
Farmers Insurance
Deloitte
AstraZeneca
Johnson and Johnson
Medtronic
Covington
McKinsey
Novartis

Generated: October 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021119

« Back to Dashboard
NDA 021119 describes VISUDYNE, which is a drug marketed by Valeant Luxembourg and is included in one NDA. It is available from two suppliers. Additional details are available on the VISUDYNE profile page.

The generic ingredient in VISUDYNE is verteporfin. There is one drug master file entry for this compound. Two suppliers are listed for this compound. Additional details are available on the verteporfin profile page.

Summary for NDA: 021119

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0

Pharmacology for NDA: 021119

Mechanism of ActionPhotoabsorption
Physiological EffectPhotosensitizing Activity

Suppliers and Packaging for NDA: 021119

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
VISUDYNE
verteporfin
INJECTABLE;INJECTION 021119 NDA Valeant Pharmaceuticals North America LLC 0187-5600 0187-5600-15 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (0187-5600-15)
VISUDYNE
verteporfin
INJECTABLE;INJECTION 021119 NDA QLT Ophthalmics, Inc. 50236-001 50236-001-15 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (50236-001-15)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength15MG/VIAL
Approval Date:Apr 12, 2000TE:RLD:Yes

Expired Orange Book Patents for NDA: 021119

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Valeant Luxembourg
VISUDYNE
verteporfin
INJECTABLE;INJECTION021119-001Apr 12, 2000► Subscribe► Subscribe
Valeant Luxembourg
VISUDYNE
verteporfin
INJECTABLE;INJECTION021119-001Apr 12, 2000► Subscribe► Subscribe
Valeant Luxembourg
VISUDYNE
verteporfin
INJECTABLE;INJECTION021119-001Apr 12, 2000► Subscribe► Subscribe
Valeant Luxembourg
VISUDYNE
verteporfin
INJECTABLE;INJECTION021119-001Apr 12, 2000► Subscribe► Subscribe
Valeant Luxembourg
VISUDYNE
verteporfin
INJECTABLE;INJECTION021119-001Apr 12, 2000► Subscribe► Subscribe
Valeant Luxembourg
VISUDYNE
verteporfin
INJECTABLE;INJECTION021119-001Apr 12, 2000► Subscribe► Subscribe
Valeant Luxembourg
VISUDYNE
verteporfin
INJECTABLE;INJECTION021119-001Apr 12, 2000► Subscribe► Subscribe
Valeant Luxembourg
VISUDYNE
verteporfin
INJECTABLE;INJECTION021119-001Apr 12, 2000► Subscribe► Subscribe
Valeant Luxembourg
VISUDYNE
verteporfin
INJECTABLE;INJECTION021119-001Apr 12, 2000► Subscribe► Subscribe
Valeant Luxembourg
VISUDYNE
verteporfin
INJECTABLE;INJECTION021119-001Apr 12, 2000► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Colorcon
Queensland Health
Covington
Fish and Richardson
Moodys
Chubb
Julphar
Citi
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot